Navigation Links
TGen/Virginia G. Piper Cancer Center publish results of new drug for pancreatic cancer patients
Date:10/4/2011

SCOTTSDALE, Ariz. -- Patients at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare were the first in the nation to participate in a clinical trial to determine the safety, tolerability and effectiveness for usage of a new drug combination consisting of a standard drug called gemcitabine and a drug called nab-paclitaxel for patients with advanced pancreatic cancer.

The results of this study, headed by renowned pancreatic cancer expert Dr. Daniel Von Hoff, were published online Oct. 3, 2011, in the prestigious Journal of Clinical Oncology.

Nab-paclitaxel (Abraxane), an albumin-bound formulation of paclitaxel, is a drug manufactured by Abraxis BioScience a wholly-owned subsidiary of Celgene and is approved for the treatment of patients with advanced breast cancer. The use of this agent in patients with pancreatic cancer is investigational.

Virginia G. Piper Cancer Center Clinical Trials is a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) to rapidly bring new discoveries in the laboratory to patients.

"This is a great example of rapid bench to bedside development," said Dr. Von Hoff, TGen's Physician-In-Chief and Chief Scientific Officer for the Scottsdale Healthcare Research Institute.

Scientists at TGen and the International Genomics Consortium, in collaboration with Abraxis scientists, found that in pancreatic cancer an albumin-binding protein called SPARC was present at high levels in cells within the pancreatic tumor microenvironment. It was hypothesized that the albumin formulation of nab-paclitaxel may be taken up by tumor cells with high SPARC expression. Based on these findings, Dr. Von Hoff -- joined by colleagues from Johns Hopkins University Hospital, Baltimore; University of Alabama, Birmingham; and South Texas Oncology-Hematology, San Antonio -- conducted a clinical trial in patients with advanced pancreatic cancer.


'/>"/>
Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. TGen, Virginia G. Piper Cancer Center studying new breast cancer drug
2. TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer
3. Enhancing arrest of cell growth to treat cancer in mice
4. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
5. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
6. Low forms of cyclin E reduce breast cancer drugs effectiveness
7. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
8. Soft drinks may increase risk of pancreatic cancer
9. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
10. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
11. Single gene mutation induces endometrial cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Liberty University has received ... program from the Council for Accreditation of Counseling ... of Liberty’s Center for Counseling & Family Studies , ... of the university’s new School of Behavioral Sciences. Prior to ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, ... Health Alliance (PPHA). The PPHA's passion for others' well-being ... NFL greats, treated for obstructive sleep apnea (OSA) has propelled ... cause in the valley. The most recent plans for an ...
(Date:1/22/2015)... 2015 AngelWeddingDress, the premier women’s dress ... wedding dresses. View website of AngelWeddingDress.com to ... maternity wedding dresses online for a bridal party. AngelWeddingDress ... quality for them. Its maternity wedding dresses are specially ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... ... Hosts Fundraiser to Establish Scholarships For Yoga Therapy Rx Program at Loyola Marymount University, ... Los Angeles, ... back specialist today announced plans for the 30th anniversary celebration of the Samata Yoga ...
... ... accident case for the amount of $37,500.00. , ... New Bedford, MA (PRWEB) May 28, 2010 -- The law firm of Dussault and Zatir ... operating his motor vehicle in Brockton, Massachusetts, when another vehicle exited a parking lot in front ...
... to be self-centered, competitive, U.S. research shows , FRIDAY, May ... reveals that American college students are not quite as empathetic ... drop in empathy after the year 2000," co-author Sara Konrath, ... Research, said in a news release. "College kids today are ...
... wide reach of the tobacco industry and its influence on ... The analyses will be published in a special July ... titled "Modeling to Advance Tobacco Control Policy." Findings are ... global event designed to heighten awareness of tobacco use and ...
... ... Histogen, Inc., a regenerative medicine company ... under embryonic conditions, will present findings today at the American ... of bioengineered, human extracellular matrix (hECM)-coated polymers showed a statistically ...
... ... to New York City in an effort to raise funds and awareness for critical diabetes research. ... (PRWEB) May 28, 2010 ... rain and shine, three fellow graduates ride for the love of their lives. , , ,Beginning ...
Cached Medicine News:Health News:"Revised Yoga for Dummies" Author and Co-Founder of International Association for Yoga Therapists Celebrates 30th Anniversary in Los Angeles 2Health News:"Revised Yoga for Dummies" Author and Co-Founder of International Association for Yoga Therapists Celebrates 30th Anniversary in Los Angeles 3Health News:"Revised Yoga for Dummies" Author and Co-Founder of International Association for Yoga Therapists Celebrates 30th Anniversary in Los Angeles 4Health News:Today's College Students More Likely to Lack Empathy 2Health News:UCSF analyses detail tobacco industry influence on health policy 2Health News:UCSF analyses detail tobacco industry influence on health policy 3Health News:Human Extracellular Matrix Significantly Improves Device Biocompatibility 2Health News:Human Extracellular Matrix Significantly Improves Device Biocompatibility 3Health News:Just Graduated College Seniors Ride for Loved Ones With Diabetes Cycling Cross Country to Raise Funds to Help Find a Cure 2Health News:Just Graduated College Seniors Ride for Loved Ones With Diabetes Cycling Cross Country to Raise Funds to Help Find a Cure 3Health News:Just Graduated College Seniors Ride for Loved Ones With Diabetes Cycling Cross Country to Raise Funds to Help Find a Cure 4
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced today ... been enrolled into the Company,s Phase 2 clinical trial. ... of Gem,s lead compound, GPX-150 (an investigational medication), in ... metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... China , Jan. 23, 2015 Tianyin Pharmaceutical ... company that specializes in the development and sale of ... generics and active pharmaceutical ingredients (API) today announced the ... (JCM) API operation. 1. Following the September ...
(Date:1/22/2015)... BOULDER, Colo. , Jan. 22, 2015  BiOptix is ... Klakamp as Vice President of Chemistry and Biochemistry. Scott ... Takeda Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course ... and development. "Scott is a nationally recognized ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
Mini: 12" x 14" Small: 14" x 16"Medium: 16" x 18" Large: 18" x 20"...
Wolfs unique apron and vest set distributes weight evenly between shoulders and hips. The vest comes with an attached Thyroid collar...
... Easy Wrap Apron has always been ... easy to put-on, adjust and take-off. ... comfortable! The new Easy sures Wrap ... the fit more easily. The attached ...
... is an advanced multi-modality system. The Easy ... that includes our 32-channel digital EEG amplifier ... recording channels like airflow, respiratory effort and ... with four DC inputs, a built-in pulse ...
Medicine Products: